Pregabalin lactam methylene dimer and preparation method therefor

US12018018B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12018018-B2
Application numberUS-201817291237-A
CountryUS
Kind codeB2
Filing dateNov 6, 2018
Priority dateNov 6, 2018
Publication dateJun 25, 2024
Grant dateJun 25, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are a pregabalin lactam methylene dimer and a preparation method therefor. The method comprises the following steps: dissolving pregabalin in a reaction solvent, reacting same with an aldehyde in an acidic system and isolating the obtained target product pregabalin lactam methylene dimer. The preparation method for pregabalin lactam methylene dimer provided by the present application has a simple operation, a high product yield, a good purity and a low cost.

First claim

Opening claim text (preview).

The invention claimed is: 1. A pregabalin lactam methylene dimer having the following structural formula: 2. A method for preparing a pregabalin lactam methylene dimer, comprising following steps: (a) adding pregabalin, an acid and an aldehyde to a reaction solvent to obtain a reaction system; (b) heating the reaction system to a temperature of 30-100° C. to react for 0.5-36 hours; and (c) obtaining the pregabalin lactam methylene dimer after the reaction is completed; wherein, the pregabalin lactam methylene dimer has the following structural formula: 3. The method according to claim 2 , wherein the reaction solvent in step (a) is selected from the group consisting of water, a polar organic solvent, and a mixture of water and the polar organic solvent. 4. The method according to claim 2 , wherein the acid in step (a) is selected from the group consisting of an organic acid, an inorganic acid, and a combination thereof. 5. The method according to claim 2 , wherein the aldehyde is selected from the group consisting of formaldehyde, formaldehyde dimer, metaformaldehyde and paraformaldehyde, or any combination thereof. 6. The method according to claim 2 , wherein a molar ratio of the acid to pregabalin in step (a) is 0.01:1-50:1. 7. The method according to claim 2 , wherein a molar ratio of the aldehyde to pregabalin in step (a) is 0.1:1-10:1. 8. The method according to claim 2 , wherein the temperature of the reaction system in step (b) is 55-75° C., and the reaction is performed for 12-24 hours. 9. The method according to claim 1 , wherein step (c) comprises: removing the reaction solvent to obtain a solid after the reaction is completed, and separating the solid to obtain the pregabalin lactam methylene dimer. 10. The method according to claim 9 , wherein separating is performed by column chromatography or preparative liquid chromatography. 11. The method according to claim 3 , wherein the polar organic solvent is selected from the group consisting of methanol, ethanol, propanol, isopropanol, acetonitrile, acetone, N,N-dimethylformamide, dimethylsulfoxide and N-methylpyrrolidone, or any combination thereof. 12. The method according to claim 4 , wherein the organic acid is selected from the group consisting of formic acid, acetic acid, trifluoroacetic acid, methanesulfonic acid, ethanesulfonic acid, benzenesulfonic acid and p-toluenesulfonic acid, or any combination thereof and the inorganic acid is selected from the group consisting of hydrochloric acid, sulfuric acid, and phosphoric acid, or any combination thereof. 13. The method according to claim 5 , wherein the aldehyde is formaldehyde or metaformaldehyde. 14. The method according to claim 6 , wherein the molar ratio of the acid to pregabalin in step (a) is 0.1:1-2.5:1. 15. The method according to claim 7 , wherein the molar ratio of the aldehyde to pregabalin in step (a) is 0.3:1-3:1.

Assignees

Inventors

Classifications

  • Optical isomers · CPC title

  • with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atom · CPC title

  • C07D403/06Primary

    linked by a carbon chain containing only aliphatic carbon atoms · CPC title

  • C07D207/27Primary

    with substituted hydrocarbon radicals directly attached to the ring nitrogen atom · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12018018B2 cover?
Provided are a pregabalin lactam methylene dimer and a preparation method therefor. The method comprises the following steps: dissolving pregabalin in a reaction solvent, reacting same with an aldehyde in an acidic system and isolating the obtained target product pregabalin lactam methylene dimer. The preparation method for pregabalin lactam methylene dimer provided by the present application h…
Who is the assignee on this patent?
Zhejiang Huahai Pharm Co Ltd, Zhejiang Huahai Zhicheng Pharmaceutical Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07D207/267. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).